While it was developed for diabetes, scientists have noticed that semaglutide might have effects beyond just lowering blood sugar
Recently, it has gained attention for its off-label use in weight loss, providing an alternative for individuals struggling with obesity
GLP-1 agonists have shown to reduce intrahepatic fat, liver enzymes, and inflammatory cytokines involved in fibrosis progression
This reduces the integrity of the fat cells, without destroying them, allowing for a gradual, non-aggressive reduction in fat volume
Hosts: Update frequency: every 17 days Average audio length: 71 minutes Guest interviews Has sponsors English United States 235 episodes since Nov
This is the one Im sticking with this time